YX-2-107
CAS No. 2417408-46-7
YX-2-107( —— )
Catalog No. M36609 CAS No. 2417408-46-7
YX-2-107 is a selective and potent CDK6-degrading PROTAC with an IC50 value of 4.4 nM.YX-2-107 inhibits RB phosphorylation and FOXM1 expression in vitro, and inhibits the development of Ph+ ALL in rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 535 | In Stock |
|
| 10MG | 852 | In Stock |
|
| 25MG | 1577 | In Stock |
|
| 50MG | 2316 | In Stock |
|
| 100MG | 3125 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYX-2-107
-
NoteResearch use only, not for human use.
-
Brief DescriptionYX-2-107 is a selective and potent CDK6-degrading PROTAC with an IC50 value of 4.4 nM.YX-2-107 inhibits RB phosphorylation and FOXM1 expression in vitro, and inhibits the development of Ph+ ALL in rats.
-
DescriptionYX-2-107 is a PROTAC (IC50= 4.4 nM) that selectively degrades CDK6. YX-2-107 effectively inhibits RB phosphorylation and FOXM1 expression in vitro and inhibits the development of Ph+ ALL in rats. YX-2-107 can be used in the study of Ph chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
-
In VitroYX-2-107 (2000 nM; 48 h) shows inhibition of S phase in Ph+ BV173 and SUP-B15 cells.YX-2-107 (0, 1.6, 8, 40, 200, 1000 nM;4 h) selectively degrades CDK6 in BV173 cells.YX-2-107 (2000 nM; 72 h) inhibits RB phosphorylation and FOXM1 expression in Ph+ BV173 and SUP-B15 cells.Cell Cycle Analysis Cell Line:Ph+ BV173 and SUP-B15 cells Concentration:2000 nM Incubation Time:48 h Result:Inhibited S-phase entry.Western Blot Analysis Cell Line:Ph+ BV173 and SUP-B15 cells Concentration:2000 nM Incubation Time:72 h Result:Inhibited the phosphorylation of RB and the expression of FOXM1.
-
In VivoYX-2-107 (10 mg/kg; i.p.; single) shows a maximum concentration of 741 nM (150-fold greater than CDK6 degradation IC50), with clearance from the plasma after 4 hours.YX-2-107 (150 mg/kg; i.p.; single daily for 3 days) is pharmacologically active in suppressing Ph+ ALL proliferation in mice.Animal Model:NRG-SGM3 mice (Ph+ ALL xenografts model).Dosage:150 mg/kg Administration:Intraperitoneal injection; single daily for 3 days Result:Suppressed the percentage of primary Ph+ ALL S-phase cells, the expression of CDK4/6-regulated phospho-RB and, to a lesser degree, FOXM1, and induced the selective CDK6 degradation.Animal Model:C57BL/6j mice.Dosage:10 mg/kg Administration:Intraperitoneal injection.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPROTACs | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2417408-46-7
-
Formula Weight889.95
-
Molecular FormulaC45H51N11O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (112.37 mM; Ultrasonic )
-
SMILESO=C1NC(=O)C(N2C(=O)C=3C=CC=C(OCC(=O)NCCCCNCC(=O)N4CCN(C5=CN=C(C=C5)NC=6N=CC7=C(N6)N(C(=O)C(C(=O)C)=C7C)C8CCCC8)CC4)C3C2=O)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. De Dominici M, et al. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs. Blood. 2020 Apr 30;135(18):1560-1573.?
molnova catalog
related products
-
5,7-Dihydroxycoumari...
5,7-Dihydroxycoumarin 7-O-β-D-glucopyranoside is a natural product that can be isolated from the roots of Morus nigra.
-
PH-002
PH-002 is an inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction in neuronal cells. It also could rescue impairments of mitochondrial motility and neurite outgrowth.
-
Sodium Hydrogen Sulf...
Sodium Hydrogen Sulfide (hydrate) is, like nitric oxide, an important gaseous mediator that has significant effects on the immunological, neurological, cardiovascular and pulmonary systems of mammals.
Cart
sales@molnova.com